Zai Lab (ZLAB) Intangibles (2016 - 2026)
Zai Lab (ZLAB) posted Intangibles of $75.8 million for Q1 2026, down 0.51% sequentially from $76.1 million in Q4 2025, and up 34.81% YoY from $56.2 million in Q1 2025.
Zai Lab (ZLAB) Intangibles (2016 - 2026) Analysis & Trends
Zai Lab has reported Intangibles for 11 years, with the latest figure at $75.8 million in Q1 2026.
- Quarterly Intangibles rose 34.81% year-over-year to $75.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.8 million (up 34.81% YoY) and the FY2025 annual result came in at $76.1 million, up 35.91% from the prior year.
- Intangibles slipped to $75.8 million in Q1 2026 per ZLAB's latest filing, from $76.1 million in the prior quarter.
- Over five years, Intangibles peaked at $76.1 million in Q4 2025 and troughed at $1.5 million in Q1 2023.
- A 5-year average of $29.9 million and a median of $13.4 million in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2024: Intangibles declined 18.24% in 2022, then soared 3195.22% in 2024.
- Over 5 years, Intangibles stood at $1.5 million in 2022, then soared by 786.1% to $13.4 million in 2023, then soared by 318.46% to $56.0 million in 2024, then surged by 35.91% to $76.1 million in 2025, then dropped by 0.51% to $75.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $75.8 million, $76.1 million, and $55.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 85.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.77 Mn |
| Mar 31, 2026 | 75.76 Mn |
| Dec 31, 2025 | 76.14 Mn |
| Sep 30, 2025 | 55.28 Mn |
| Jun 30, 2025 | 56.52 Mn |
| Mar 31, 2025 | 56.20 Mn |
| Dec 31, 2024 | 56.03 Mn |
| Sep 30, 2024 | 51.67 Mn |
| Jun 30, 2024 | 44.06 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 1.68 Mn |